Suppr超能文献

C反应蛋白:敌还是友?从重金属到修饰脂蛋白及新型冠状病毒2的系统发生

C-Reactive Protein: Friend or Foe? Phylogeny From Heavy Metals to Modified Lipoproteins and SARS-CoV-2.

作者信息

Torzewski Michael

机构信息

Department of Laboratory Medicine and Hospital Hygiene, Robert Bosch-Hospital, Stuttgart, Germany.

出版信息

Front Cardiovasc Med. 2022 Mar 24;9:797116. doi: 10.3389/fcvm.2022.797116. eCollection 2022.

Abstract

Animal C-reactive protein (CRP) has a widespread existence throughout phylogeny implying that these proteins have essential functions mandatory to be preserved. About 500 million years of evolution teach us that there is a continuous interplay between emerging antigens and components of innate immunity. The most archaic physiological roles of CRP seem to be detoxication of heavy metals and other chemicals followed or accompanied by an acute phase response and host defense against bacterial, viral as well as parasitic infection. On the other hand, unusual antigens have emerged questioning the black-and-white perception of CRP as being invariably beneficial. Such antigens came along either as autoantigens like excessive tissue-stranded modified lipoprotein due to misdirected food intake linking CRP with atherosclerosis with an as yet open net effect, or as foreign antigens like SARS-CoV-2 inducing an uncontrolled CRP-mediated autoimmune response. The latter two examples impressingly demonstrate that a component of ancient immunity like CRP should not be considered under identical "beneficial" auspices throughout phylogeny but might effect quite the reverse as well.

摘要

动物C反应蛋白(CRP)在整个系统发育过程中广泛存在,这意味着这些蛋白质具有必须保留的基本功能。大约5亿年的进化历程告诉我们,新出现的抗原与先天免疫成分之间存在持续的相互作用。CRP最古老的生理作用似乎是重金属和其他化学物质的解毒作用,随后或伴随着急性期反应以及针对细菌、病毒和寄生虫感染的宿主防御。另一方面,出现了一些不同寻常的抗原,这对将CRP一概视为有益的黑白认知提出了质疑。这些抗原要么是自身抗原,如由于食物摄入错误导致过多组织滞留的修饰脂蛋白,将CRP与动脉粥样硬化联系起来,其净效应尚待明确;要么是外来抗原,如严重急性呼吸综合征冠状病毒2(SARS-CoV-2),引发不受控制的CRP介导的自身免疫反应。后两个例子令人印象深刻地表明,像CRP这样古老免疫的一个组成部分,在整个系统发育过程中不应被视为始终处于相同的“有益”条件下,其影响也可能恰恰相反。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b621/8987351/d4607e609d5a/fcvm-09-797116-g0001.jpg

相似文献

1
C-Reactive Protein: Friend or Foe? Phylogeny From Heavy Metals to Modified Lipoproteins and SARS-CoV-2.
Front Cardiovasc Med. 2022 Mar 24;9:797116. doi: 10.3389/fcvm.2022.797116. eCollection 2022.
4
Atherosclerosis-related functions of C-reactive protein.
Cardiovasc Hematol Disord Drug Targets. 2010 Dec 1;10(4):235-40. doi: 10.2174/187152910793743841.
6
Phylogeny and expression analysis of C-reactive protein (CRP) and serum amyloid-P (SAP) like genes reveal two distinct groups in fish.
Fish Shellfish Immunol. 2017 Jun;65:42-51. doi: 10.1016/j.fsi.2017.03.037. Epub 2017 Mar 20.
10

引用本文的文献

2
An evolutionarily conserved function of C-reactive protein is to prevent the formation of amyloid fibrils.
Front Immunol. 2024 Sep 16;15:1466865. doi: 10.3389/fimmu.2024.1466865. eCollection 2024.
3
Editorial: Biology of C-reactive protein.
Front Immunol. 2024 Jun 19;15:1445001. doi: 10.3389/fimmu.2024.1445001. eCollection 2024.
4
Genetic evidence for the causal effects of C-reactive protein on self-reported habitual sleep duration.
Brain Behav Immun Health. 2024 Mar 11;37:100754. doi: 10.1016/j.bbih.2024.100754. eCollection 2024 May.
5
The Potential Role of C-Reactive Protein in Metabolic-Dysfunction-Associated Fatty Liver Disease and Aging.
Biomedicines. 2023 Oct 5;11(10):2711. doi: 10.3390/biomedicines11102711.
8
Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils.
J Immunol. 2022 Sep 15;209(6):1180-1188. doi: 10.4049/jimmunol.2200148. Epub 2022 Aug 17.
9
Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons.
J Clin Med. 2022 Mar 23;11(7):1771. doi: 10.3390/jcm11071771.

本文引用的文献

1
The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus.
J Clin Med. 2021 Dec 13;10(24):5837. doi: 10.3390/jcm10245837.
2
The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection.
Int J Mol Sci. 2021 Oct 25;22(21):11488. doi: 10.3390/ijms222111488.
3
Case Report: C-Reactive Protein Apheresis in a Patient With COVID-19 and Fulminant CRP Increase.
Front Immunol. 2021 Aug 2;12:708101. doi: 10.3389/fimmu.2021.708101. eCollection 2021.
5
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study.
Front Cardiovasc Med. 2021 Mar 10;8:591714. doi: 10.3389/fcvm.2021.591714. eCollection 2021.
6
Recent Application of Zebrafish Models in Atherosclerosis Research.
Front Cell Dev Biol. 2021 Feb 25;9:643697. doi: 10.3389/fcell.2021.643697. eCollection 2021.
7
COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes.
Front Immunol. 2021 Jan 29;11:599736. doi: 10.3389/fimmu.2020.599736. eCollection 2020.
8
Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.
PLoS One. 2020 Nov 17;15(11):e0241955. doi: 10.1371/journal.pone.0241955. eCollection 2020.
9
Two distinct immunopathological profiles in autopsy lungs of COVID-19.
Nat Commun. 2020 Oct 8;11(1):5086. doi: 10.1038/s41467-020-18854-2.
10
How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression.
Front Immunol. 2020 Sep 10;11:2126. doi: 10.3389/fimmu.2020.02126. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验